LifeStance CTO shares withheld for RSU taxes

LifeStance Health Group’s Chief Technology Officer, Vukasin Paunovich, reported a tax-related share withholding tied to vested restricted stock units.

Accepted by SEC EDGAR 06/15/2026 - 08:41 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

LifeStance Health Group’s Chief Technology Officer, Vukasin Paunovich, reported a tax-related share withholding tied to vested restricted stock units. On June 11, 2026, 17,456 shares of common stock were withheld by the company at $8.61 per share to cover tax obligations, and this was not an open-market sale. After this net settlement, Paunovich directly holds 291,840 shares of LifeStance common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 17,456 shares

Exercise Price or Tax Liability 1 txn

Insider Paunovich Vukasin

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	17,456	$8.61	$150K

Holdings After Transaction: Common Stock — 291,840 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on June 11, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

Key Figures

Tax-withholding shares: 17,456 shares Withholding price: $8.61 per share Shares held after transaction: 291,840 shares +1 more

4 metrics

Tax-withholding shares 17,456 shares Shares withheld for RSU tax obligations on June 11, 2026

Withholding price $8.61 per share Value used for withheld LifeStance common stock

Shares held after transaction 291,840 shares CTO direct LifeStance common stock holdings after June 11, 2026

Tax-withholding transactions 1 transaction, 17,456 shares Summary of F-code tax-withholding dispositions in this Form 4

Key Terms

restricted stock units ("RSUs"), tax withholding obligations, net settlement, open-market sale

4 terms

restricted stock units ("RSUs") financial

"in connection with the net settlement of restricted stock units ("RSUs") that vested on June 11, 2026"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

tax withholding obligations financial

"shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement"

net settlement financial

"in connection with the net settlement of restricted stock units ("RSUs") that vested on June 11, 2026"

open-market sale financial

"do not constitute any open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LifeStance (LFST) report for CTO Vukasin Paunovich?

LifeStance reported that CTO Vukasin Paunovich had 17,456 shares of common stock withheld on June 11, 2026 to satisfy tax obligations on vested RSUs. This was a net settlement mechanism and not an open-market sale of shares.

Was the LifeStance (LFST) CTO’s Form 4 transaction an open-market sale?

No, the Form 4 states the 17,456 LifeStance shares were withheld by the issuer to cover tax withholding for vested RSUs. The footnote clarifies this reduction did not constitute any open-market sale of LifeStance Health Group common stock.

How many LifeStance (LFST) shares does the CTO hold after the reported transaction?

Following the tax-withholding share reduction, CTO Vukasin Paunovich directly holds 291,840 shares of LifeStance common stock. This figure reflects his position after the RSU vesting and related net settlement on June 11, 2026.

What price was used for the LifeStance (LFST) tax-withholding shares on June 11, 2026?

The 17,456 LifeStance shares withheld for tax obligations were valued at $8.61 per share. This per-share figure comes directly from the Form 4 transaction details for the June 11, 2026 RSU-related withholding event.

What does an F-coded transaction mean in the LifeStance (LFST) Form 4?

In this Form 4, the F code indicates a tax-withholding disposition. LifeStance withheld 17,456 shares from the CTO to pay tax obligations on vested RSUs, reducing shares issued to him rather than reflecting any market sale activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Paunovich Vukasin

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		F(1)		17,456	D	$8.61	291,840	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on June 11, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

	By: /s/ Ryan Pardo, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)